UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1608-1632

2020

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6251-6266

2009

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

Journal of clinical oncology, 2022-10, Vol.40 (28), p.3323-3343

2022

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2021-03, Vol.39 (9), p.1040-1091

2021

Volltextzugriff (PDF)

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5892-5899

2005

Volltextzugriff (PDF)

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5900-5909

2005

Volltextzugriff (PDF)

Recent Clinical Advances in Lung Cancer Management

Journal of clinical oncology, 2014-04, Vol.32 (10), p.973-982

2014

Volltextzugriff (PDF)

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Volltextzugriff (PDF)

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2121-2127

2011

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3484-3515

2017

Volltextzugriff (PDF)

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3911-3920

2015

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

Journal of clinical oncology, 2022-10, Vol.40 (28), p.3310-3322

2022

Volltextzugriff (PDF)

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Journal of clinical oncology, 2010-01, Vol.28 (1), p.29-34

2010

Volltextzugriff (PDF)

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1398-1404

2013

Volltextzugriff (PDF)

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2184-2191

2004

Volltextzugriff (PDF)

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599

Journal of clinical oncology, 2010-02, Vol.28 (6), p.949-954

2010

Volltextzugriff (PDF)

Induction Chemoradiation and Surgical Resection for Superior Sulcus Non–Small-Cell Lung Carcinomas: Long-Term Results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)

Journal of clinical oncology, 2007-01, Vol.25 (3), p.313-318

2007

Volltextzugriff (PDF)

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2544-2555

2005

Volltextzugriff (PDF)

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2060-2065

2011

Volltextzugriff (PDF)

American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003

Journal of clinical oncology, 2004-01, Vol.22 (2), p.330-353

2004

Volltextzugriff (PDF)

Setting the bar for therapeutic trials in non-small-cell lung cancer: how low can we go?

Journal of clinical oncology, 2014-05, Vol.32 (14), p.1389-1391

Johnson, David H

2014

Volltextzugriff (PDF)

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Journal of clinical oncology, 2008-01, Vol.26 (1), p.60-65

2008

Volltextzugriff (PDF)

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

Journal of clinical oncology, 2008-03, Vol.26 (9), p.1472-1478

2008

Volltextzugriff (PDF)

1 – 25 von 472

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(472)
Mit Volltextzugriff
(450)

Publikationsform

Artikel
(472)

Sprache

Englisch
(472)
Japanisch
(47)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(148)
Life Sciences & Biomedicine
(147)
Oncology
(147)
Science & Technology
(147)
Female
(103)
Male
(101)
Biological And Medical Sciences
(100)
Medical Sciences
(100)
Middle Aged
(99)
Aged
(86)
Adult
(77)
Tumors
(67)
Lung Neoplasms - Drug Therapy
(64)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(63)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(48)
Treatment Outcome
(43)
Pneumology
(39)
Tumors Of The Respiratory System And Mediastinum
(39)
Lung Neoplasms - Pathology
(38)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(30)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(472)
Journals@Ovid Ovid Full Text
(472)
Single Journals
(472)
IngentaConnect Journals
(267)
IngentaConnect
(267)
MEDLINE
(149)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(3)

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

Recent Clinical Advances in Lung Cancer Management

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599

Induction Chemoradiation and Surgical Resection for Superior Sulcus Non–Small-Cell Lung Carcinomas: Long-Term Results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003

Setting the bar for therapeutic trials in non-small-cell lung cancer: how low can we go?

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

Aktive Filter

Suchergebnisse filtern